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Background: Rhabdomyolysis is a potentially life-threatening syndrome that can develop from a variety of causes.
The aim of the work is to analyze the clinical spectrum and to evaluate the prevalence of various etiologies in
children, who present to the emergency department (ED) with rhabdomyolysis.
Methods: During a 6-year study period, we retrospectively analyzed the medical charts of patients, aged 18 years
or younger, with a definite diagnosis of rhabdomyolysis and serum creatinine phosphokinase (CK) levels greater
than 1000IU/L. We analyzed the clinical spectrum and evaluated the potential risk factors of acute renal failure
(ARF).
Results: Thirty-seven patients (mean age = 10.2 ± 5.5 years), including 26 males and 11 females, were enrolled in
the study. Two of the most common presented symptoms in these 37 patients were muscle pain and muscle
weakness (83.8% and 73%, respectively). Dark urine was reported in only 5.4% of the patients. The leading cause of
rhabdomyolysis in the 0- to 9-year age group was presumed infection, and the leading cause in the 10- to 18-year
age group was trauma and exercise. The incidence of ARF associated with rhabdomyolysis was 8.1 % and no child
needed for renal replacement therapy (RRT). We did not identify any reliable predictors of ARF or need for RRT.
Conclusions: The classic triad of symptoms of rhabdomyolysis includes myalgia, weakness and dark urine are not
always presented in children. The cause of rhabdomyolysis in younger age is different from that of teenager group.
However, the prognosis of rhabdomyolysis was good with appropriate management.
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Rhabdomyolysis is characterized by skeletal muscle
breakdown with leakage of muscle contents, including
electrolytes, myoglobin, and other sarcoplasmic proteins
(e.g. creatine kinase, lactate dehydrogenase, alanine ami-
notransferase, and aspartate aminotransferase) into the
circulation [1,2]. Its major causes in children, include in-
fections, trauma, exertion, drugs, toxins, metabolic dis-
orders and electrolyte disorders [2-5]. Typically,
rhabdomyolysis patients present with muscle pain, weak-
ness, and reddish-brown urine. Nevertheless, the severity
of rhabdomyolysis varies from an asymptomatic increase* Correspondence: arthur1226@gmail.com
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reproduction in any medium, provided the orin creatine phosphokinase (CK) to heavy complications,
such as acute renal failure (ARF), cardiac arrhythmias,
compartmental syndrome, hypovolemic shock and dis-
seminated intravascular coagulopathy [4-10].
As we know, ARF is the most recognized complication
of rhabdomyolysis. In a larger study of 191 children with
a CK level greater than 1000 IU/L who were sent to the
emergency department (ED), the prevalence of ARF was
5% [11]. However, after the search of the related litera-
ture, it would appear that research discussing rhabdo-
myolysis in children that also presented to the pediatric
ED is still rare. Therefore, in this study, we analyzed the
clinical spectrum and prevalence of various etiologies in
children with rhabdomyolysis that presented to the
pediatric ED.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Patient population
This study was a single-center medical chart review of
patients aged 18 years or younger who presented to the
ED with a diagnosis of rhabdomyolysis based on their
medical histories and elevated serum creatine kinase
(CK) levels (>1000 IU/L) within 72 hours after admission
to the ED. We identified potentially eligible patient visits
by searching the Changhua Christian Hospital health
records database. We selected charts with any of the fol-
lowing search terms in the primary or secondary dis-
charge diagnosis fields: rhabdomyolysis (ICD-9 728.88),
infective myositis (ICD-9 728.0), myalgia and myositis
(ICD-9 729.1), and myoglobinuria (ICD-9 791.3). We
reviewed 445 medical charts of all eligible patients dur-
ing a 6-year period from January 2006 to December
2011. Four hundred and eight patient charts were ex-
cluded (for having initial serum CK levels < 1000 IU/L
or showing a documented history of muscular dystrophy
or other metabolic muscle disorder, a history of myocar-
dial infarction, a history of chronic kidney disease,
rhabdomyolysis that developed after admission to the
hospital due to a coexisting condition or iatrogenic com-
plication, or ages greater than 18 years). In total, 37
(8.3%) of the 445 patients were included into this series.
The study was approved by the Institutional Review








Variables N % N % N % P-value
Gender Female 11 32.4 0 0 11 29.7 0.540
Male 23 67.6 3 100 26 70.3
Muscular pain Yes 29 85.3 2 66.7 31 83.8 0.421
Muscular weakness Yes 26 76.5 1 33.3 27 73 0.172
Muscular swelling Yes 3 8.8 0 0 3 8.1 1.000
Dark urine Yes 2 5.9 0 0 2 5.4 1.000
Fever Yes 22 64.7 3 100 25 67.6 0.537
Admission unit OU 14 41.2 0 0 14 37.8 0.169
Ward 18 52.9 2 66.7 20 54.1
ICU 2 5.9 1 33.3 3 8.1
ARF acute renal failure, OU observation unit, ICU intensive care unit.Methods
Information about related clinical factors that was po-
tentially causative for rhabdomyolysis were reviewed
from the medical records of patients who met the inclu-
sion criteria. The following information was obtained
from the medical records of each patient: age, gender,
family history, associated symptoms and signs (fever, lo-
calized muscle pain, dark urine, muscle weakness or al-
tered mental status, muscle swelling and history of
upper respiratory tract infection), laboratory tests [initial
and peak serum white blood cell (WBC), hemoglobin
(Hb), CK level, electrolytes, blood urea nitrogen (BUN),
creatinine (Cr), lactic dehydrogenase, alanine and aspar-
tate aminotransferase levels, myoglobin levels], and urine
toxicology screens for amphetamine, opiates, barbitu-
rates, and benzodiazepines. Other clinical data included
fluid administered within the first 24 hours, bicarbonate
therapy, development of renal failure, need for renal re-
placement therapy (RRT), length of hospital stay, death,
and final causes of the rhabdomyolysis and ARF. We
also evaluated follow-up data, including CK, Cr,
myoglobulin, and any documentation of renal sequelae.
Rhabdomyolysis was defined as serum CK greater than
1000 IU/L in the absence of any previous cardiac eti-
ology or genetic muscular dystrophy. Acute renal failurewas defined as a serum creatinine level of more than the
97.5th percentile for the patient’s age and gender [12].
Renal replacement therapy (RRT) was defined as the
use of either peritoneal dialysis, hemodialysis (HD) or
continuous renal replacement therapy (CRRT). We ana-
lyzed the clinical spectrum and prevalence of various eti-
ologies in children with rhabdomyolysis presented to the
ED and also evaluates the potential risk factors of ARF.
Statistical analysis
Data of categorical variables were analyzed by the chi-
square test or Fisher’s exact test, when appropriate. Con-
tinuous variables were analyzed by the Student’s t-test. A
P value less than 0.05 was considered to be statistically
significant. Distributions of variables were reported as
percentages and mean ± standard deviation (SD). Statis-
tical analyses were performed using SPSS software (ver-
sion 15.0; SPSS Inc., Chicago, IL, USA).
Results
During the 6-year study period, about 165,000 children
presented to our pediatric ED. This study included 37
patients (mean age = 10.2 ± 5.5 years), 26 males and 11
females, who presented to the pediatric ED with
rhabdomyolysis and met the inclusion criteria. Of the
37 patients, 11 (29.7%) were younger than 7 years. Two
of the most commonly presented symptoms among the
37 patients were muscle pain and muscle weakness
(83.8% and 73%, respectively). Among them, 25 (67.6%)
presented with fever and dark urine was reported in
only 5.4% of the patients (Table 1). Three (8.1%) of
these 37 patients were admitted to intensive care unit
(ICU). The duration of hospital stay was longer in pa-
tients with ARF than those without ARF (8.7 ± 6.4 days
and 3.4 ± 3.7 days, respectively, P = 0.04). All the 37








Cause N (%) N (%) N (%) P-value
Trauma 6 (17.6) 0 (0.0) 6 (16.2) 0.035*
Exercise 6 (17.6) 0 (0.0) 6 (16.2)
Infection 21 (61.8) 1 (33.3) 22 (59.5)
Metabolic and electrolyte 1 (2.9) 1 (33.3) 2 (5.4)
Body-temperature change 0 (0.0) 1 (33.3) 1 (2.7)
*Statistically significant by the chi-square test or Fisher’s exact test
when appropriate.
ARF acute renal failure.
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single diagnosis based on the patient’s discharge diagnosis
or diagnosis through subspecialty follow-up assessments
(Table 2). The most common causes of rhabdomyolysis in
this sample were infections (n = 22, 59.5%) and the virus
was identified in 5 patients (Influenza type B in 4;
Coxsackie A10 in 1). For the traumatic causes, traffic acci-
dents (n = 6, 100%) were the major cause and none of
these 6 patients were complicated with ARF, including a
4-year-old girl with major trauma. For the 6 patients
where involvement was caused by exercise, all of them
were in the adolescent group. All cases received a large
amount of fluid administration within the first 24 hours,
but only one required bicarbonate therapy.
The leading cause of rhabdomyolysis in the 0 to 9-year
age group was presumed infection, and the leading cause
in the 10- to 18-year age group was trauma and exercise
(Figure 1). Moreover, three patients complicated with
ARF and no patient needed RRT (Table 3). All 3 patients
survived and had normal creatinine levels documented
during follow-up visits.
The peak serum CK level in those 37 patients was
9825.1 ± 23079.1 U/L, there was no difference between
the ARF and non-ARF groups (Table 4). The serum level
of myoglobin was checked in half of our study patientsFigure 1 Etiologies of children with rhabdomyolysis in different age gand the peak value in those 16 patients was 1634.8 ±
2334.4 ng/mL. There was no significant difference be-
tween the in ARF and non-ARF groups. BUN and Cre-
atinine were significantly higher in the ARF group
compared to the non-ARF group.
Discussion
Rhabdomyolysis is a potentially life-threatening syn-
drome that can develop from a variety of causes; the
classic triad of symptoms includes muscle pain, weak-
ness, and dark urine and may not always be present in
children [4-10,13]. In 2006, an adult study showed that
45% presented with myalgia, 38% had muscle weakness
and only 3.6% noted dark urine [12]. In our study, we
recorded 83.8% presented with myalgia, 73% had muscle
weakness but dark urine was observed in only 5.4%.
There was only one patient presented with the classic
triad of symptoms. In our study, we also found the male
to female ratio of pediatric rhabdomyolysis was 2.3:1.
The result was similar to the two other studies of
rhabdomyolysis which the male to female ratio were 2:1
and 4:1, respectively. [11,12].
The etiologies of rhabdomyolysis can be classified as
hereditary and acquired. The acquired causes are further
classified as traumatic and non-traumatic [14]. In
pediatric patients, the most common causes are viral
myositis, trauma, connective tissue disorders, seizure,
physical exertion, and drug overdose [11,12]. In our
series, infections accounted for more than half (59.5%)
of the causes of rhabdomyolysis, followed by trauma
(16.2%) and exercise (16.2%). In patients that were 9
years old or younger, infections was the most common
cause of rhabdomyolysis and accounted for 19 of 21 pa-
tients in this age group. However, the most common
cause of rhabdomyolysis in patients older than 9 years
was physical exertion. Rhabdomyolysis has been
reported to be associated with a variety of viral infec-
tions, including influenza, [15,16] Coxsackie virus, hu-
man immunodeficiency virus (HIV), echovirus androups.
Table 3 Details of the pediatric patients with acute renal failure












































CK serum creatine kinase, GTC generalized tonic-clonic seizure, EEG electroencephalography, CT computed tomography.
Table 4 Comparison of laboratory tests of patients
between AFR and non-ARF groups
Non-ARF ARF P-
value
N Mean SD N Mean SD
WBC (× 109/L) 33 7796.1 5734.0 3 17663.3 9229.2 0.056
BUN (mg/dl) 19 8.6 2.9 3 36.6 14.9 0.001*
Creatinine (mg/dl) 31 0.6 0.3 3 3.1 0.8 <0.001*
ALT (U/L) 19 121.8 254.0 3 71 24.6 0.218
AST (U/L) 11 285.1 354.6 3 80.0 40.1 0.555
Sodium (mmol/L) 28 138.8 2.1 3 135.7 7.4 0.392
Potassium (mmol/
L)
29 3.8 0.5 3 4.0 0.5 0.666
CK-peak (U/L) 34 10413.6 24001.2 3 3154.3 3167.6 0.814
CK-initial (U/L) 16 2809.2 3436.4 3 1281.7 128.6.5 0.712
Myoglobin-peak
(ng/mL)
15 1675.1 2410.5 1 1030 0.75
Myoglobin-initial
(ng/mL)
9 1262.2 1585.2 1 1030 0.60
*Statistically significant by Student’s t-test.
WBC white blood count, BUN blood urea nitrogen, ALT alanine
aminotransferase, AST aspartate aminotransferase, CK creatine phosphokinase.
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fection was identified in 5 patients (influenza type B in
4, Coxsackie A10 in 1) and none of them were compli-
cated with ARF. In these 6 patients that presented with
rhabdomyolysis caused by trauma, traffic accident was
the major cause and none of these 6 patients were com-
plicated with ARF.
ARF is a major life-threatening complication of
rhabdomyolysis and requires immediately adequate
managements. Previous studies reported the rates of
ARF secondary to rhabdomyolysis range from 17-35% in
adults and from 42-50% in children [18-21]. However, in
the recently larger pediatric studies reported by Mannix
et al [12] and Wu et al [11] it was shown that the rate of
ARF with pediatric rhabdomyolysis ranged from 5–8.7
%. The indications for RRT include severe and resistant
hyperkalemia, an abrupt increase in potassium levels,
persistent metabolic acidosis, and ongoing ARF despite
conservative treatment [22-24]. Based on previous stud-
ies [11,12], the rate of RRT was from 1.6-2.9% in chil-
dren with rhabdomyolysis. In our study, we found a
lower rate (8.1%) of ARF, and our series showed no one
treated with RRT. The outcome of patients examined in
this study was considered to be good.
To prevent ARF, the early recognition and appropriate
treatment of rhabdomyolysis is vital. Furthermore, the
predictors of ARF have been investigated in previous
studies [3,5,10-12,25]. Serum CK represents a more reli-
able marker than blood myoglobin for the diagnosis and
assessment of the severity of rhabdomyolysis because it
lasts for longer periods than blood myoglobin [3]. How-
ever, elevated serum CK has not been shown to well cor-
relate with the severity of ARF, [5,25] although some
studies showed a predictive correlation between CK and
ARF [10,11]. Our study also indicates that the initial and
peak value of CK is not a good predictor of ARF. Below
are some probable reasons to explain that the peak level
of CK and myoglobine is higher in the non-ARF group
as compared to the ARF group in our study. First, there
was a small sample size included in our study whichonly contained 3 patients with ARF. Second, the labora-
tory data were not regularly followed up in all patients,
and this may lead to difficulty in determining the defin-
ite peak data. Third, the pathophysiology of rhabdo-
myolysis is heterogeneous and this may cause the
different appearance of laboratory data based on differ-
ent etiologies of rhabdomyolysis. Moreover, the definite
relationship between peak CK or myoglobin and ARF
caused by different etiologies of rhabdomyolysis is not
clear enough. A recent adult study, conducted by
Kasaoka et al [25], suggested that the serum myoglobin
level on admission did not predict ARF, but that the
peak value of serum myoglobin might be a predictive
factor of ARF. The best cutoff value for serum myoglo-
bin was 3865 ng/mL. But due to the relatively small
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tive conclusion. However, our study showed no signifi-
cant differences in laboratory findings that could help to
predict ARF earlier in patients with rhabdomyolysis.
There is still a lack of randomized controlled trials for
the best treatment in children with rhabdomyolysis to be
conducted till now. However, regardless of underlying eti-
ologies, the important aspects of treatments for rhabdo-
myolysis are considered to be conservative [6,13,26].
Clinically, managements may include prompt and aggres-
sive fluid resuscitation, prevention of progressing to
ARF, early correction of potentially lethal electrolyte
disturbance, correction of severe metabolic acidosis,
and managements of other coexisting complications
[6,13,26]. In addition, for adults, the addition of manni-
tol and bicarbonate after the initial fluid resuscitation
to prevent ARF has been recommended (especially for
crush injury) in some studies [13,27,28]. But, the role of
mannitol or bicarbonate in the treatment for rhabdo-
myolysis in children remains controversial [26]. Al-
though causes of rhabdomyolysis are wide variety and
the definite pathophysiology and development of ARF
are complicated, the main therapeutic intervention to
avoid ARF should be fluids and hydration [6,13,26].
Therefore, once the diagnosis of rhabdomyolysis in
children is made in the ED, aggressive intravenous fluid
rehydration will be indicated.
The present study has a number of limitations. First,
in a retrospective single center review of medical re-
cords, some details of history and physical examinations
may not be rigorously documented. Second, the rela-
tively small sample size may fail to address definitely
predictive factors of ARF. Finally, the laboratory data
were not regularly followed up in some patients and the
definite peak data was therefore difficult to record.
These limitations may have led to some bias in analyzing
the clinical spectrum of rhabdomyolysis in children who
presented to the ED.Conclusion
Infection was the major cause of rhabdomyolysis in chil-
dren younger than 10 years; however, the leading causes
in the teenager group were trauma and exercise. In our
study, the classic triad of symptoms of rhabdomyolysis
included myalgia, weakness and dark urine were rarely
presented and the incidence of ARF associated with
rhabdomyolysis was 8.1%. Although our study did not
identify any unique predictors of ARF or need for RRT,
the prognosis of rhabdomyolysis was good with appro-
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